HRMY
Harmony Biosciences Holdings Inc
Price:  
35.21 
USD
Volume:  
653,071
United States | Pharmaceuticals

HRMY Gross Margin

As of 2025-07-17, the Gross Margin of Harmony Biosciences Holdings Inc (HRMY) is 78.1%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

HRMY Gross Margin - Historical Value
DateValue
2024-12-31 78.1%
2023-12-31 79.2%
2022-12-31 80.9%
2021-12-31 81.8%
2020-12-31 82.7%
2019-12-31 73.3%
2018-12-31 -
-
-
-
HRMY Gross Margin - Peers Comparison